Recruiting
Early Phase 1

Observational Study

Sponsor:

Wright State University

Code:

NCT03932162

Conditions

UVB Phototherapy Burn

Insulin-like Growth Factor 1

Aging

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Interventions

Insulin-Like Growth Factor 1

No Insulin-Lie Growth Factor 1

Study Details

Brief summary:

This study does not involve any particular diagnosis. The goal of this research study is to explore the effects of artificial sunlight (ultraviolet B radiation; UVB) on the skin of young adults versus geriatric adults. Sunlight exerts many effects on the body. There is evidence that in response to ultraviolet B radiation (UVB), which are the burning rays of sunlight, young adult skin responds differently than geriatric skin. In fact, researchers feel that this difference in how the skin reacts to UVB is why skin cancers are found in older skin. Researchers believe that a major difference between young adult and geriatric skin is that young skin has a lot of a protein called insulin-like growth factor-1 (IGF-1), whereas geriatric skin has very little. The current study will test how young adult versus geriatric skin responds to UVB, and if geriatric skin treated with an injection of small amount of IGF-1 drug will then act like young skin.

Conditions

UVB Phototherapy Burn

Insulin-like Growth Factor 1

Aging

Study ID

NCT03932162

Start date

Sep 6, 2019

Status verified date

Feb, 2025

Completion date

Dec, 2025

Anticipated

Primary completion date

Dec, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Male/Female
  • White skin (Fitzpatrick types I and II)
  • Age 21-30 or 65 and older
  • Able to comprehend procedures/risks

Exclusion Criteria:

  • Known photosensitivity
  • Currently on photosensitizing medications
  • Diabetes Mellitus
  • History of abnormal scarring
  • History of skin infections
  • Known allergy to lidocaine local anesthetic
  • Pregnancy or nursing
  • Other serious health issues

Study Design

Enrollment

24 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

placebo comparator: Young Adult

One small area of skin will undergo treatment with a small amount of UVB.

active comparator: Geriatric Adult

Four small areas will undergo injection of a small amount of IGF-1 drug and two will undergo injections with saline. Then the injected areas will be treated with a small amount of UVB.

Interventions

Insulin-Like Growth Factor 1

Growth factor protein

No Insulin-Lie Growth Factor 1

No Insulin-Like Growth Factor 1 will be given.

Primary outcome measure

  • Change in expression genes involved in protecting skin cells from UVB damage in younger skin and geriatric skin injected with IGF-1 from baseline [ Time Frame: 2 Days ]

Central Contacts and Locations

Central contacts

Locations

Wright State Physicians

Recruiting

Fairborn, Ohio, United States, 45324

More Information

Sponsor

Wright State University

Last update posted

Feb 6, 2025

Last verified

Feb, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Wright State University on 2025-02-06.